Evidence map›Paper›PMID 41427528›Full record

ArticleACS chemical biology2026

Consequences of Peptide Macrocyclization Revealed by Virus-Inspired β-Hairpin Mimetics.

Anna L Bula, Raitis Bobrovs, Pavel Arsenyan, Teodors Pantelejevs

Abstract read
In one paragraph

Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna L BulaLatvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia.
Raitis BobrovsLatvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia.
Pavel ArsenyanLatvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia.ORCID 0000-0001-5875-2799
Teodors PantelejevsLatvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia.ORCID 0000-0003-2220-6379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mimicry of protein secondary structure elements, such as α-helices and β-sheets, using conformationally constrained peptide macrocycles, can be utilized to disrupt native protein-protein and protein-nucleic acid interactions. Although α-helical stapled peptides have been extensively studied as pharmacological probes, the application of β-sheet and β-hairpin mimetics remains comparatively limited. Less is known about the structural and biophysical consequences of β-hairpin macrocyclization in the context of target binding. In this work, we use a poxvirus immune antagonist protein 018 as a template for the structure-based design of β-hairpin mimetic macrocyclic peptides targeting the STAT1 transcription factor. We demonstrate that successive orthogonal cyclizations have additive effects on the thermodynamic and kinetic properties of peptide binding, most notably slowing the dissociation from the target. We elucidate the structural and dynamic consequences of interstrand and head-to-tail cross-linking and propose a kinetic model explaining the gains in target residence. Finally, we highlight the pharmacological potential of these peptides by competitive inhibition of STAT1 binding to its cognate interferon receptor docking site. These data suggest that β-hairpin macrocyclization may represent a general strategy to extend target engagement, with implications for peptidic probe design.

Indexed as

PeptidesPeptides, CyclicSTAT1 Transcription FactorViral ProteinsCyclizationHumansKineticsProtein BindingThermodynamicsPeptidesPeptides, CyclicSTAT1 protein, humanSTAT1 Transcription FactorViral Proteins

Identifiers

PMID41427528
PMCPMC12813973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.